CHD-loss promotes tumor heterogeneity, lineage plasticity and resistance to AR targeted therapy resistance

被引：0
|
作者：
Mu, P. [1 ]
机构：
[1] UT Southwestern Med Ctr, Mol Biol, Dallas, TX USA
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
52
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 50 条
  • [21] The great escape: tumour cell plasticity in resistance to targeted therapy
    Soufiane Boumahdi
    Frederic J. de Sauvage
    Nature Reviews Drug Discovery, 2020, 19 : 39 - 56
  • [22] The great escape: tumour cell plasticity in resistance to targeted therapy
    Boumahdi, Soufiane
    de Sauvage, Frederic J.
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (01) : 39 - 56
  • [23] Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma
    Jung, Erik
    Osswald, Matthias
    Ratliff, Miriam
    Dogan, Helin
    Xie, Ruifan
    Weil, Sophie
    Hoffmann, Dirk C.
    Kurz, Felix T.
    Kessler, Tobias
    Heiland, Sabine
    von Deimling, Andreas
    Sahm, Felix
    Wick, Wolfgang
    Winkler, Frank
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [24] Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma
    Erik Jung
    Matthias Osswald
    Miriam Ratliff
    Helin Dogan
    Ruifan Xie
    Sophie Weil
    Dirk C. Hoffmann
    Felix T. Kurz
    Tobias Kessler
    Sabine Heiland
    Andreas von Deimling
    Felix Sahm
    Wolfgang Wick
    Frank Winkler
    Nature Communications, 12
  • [25] Osteopontin promotes tumor microenvironment remodeling and therapy resistance
    Liu, Chao
    Xia, Shunjin
    Wang, Bo
    Li, Jiayong
    Wang, Xuyan
    Ren, Yu
    Zhou, Xuan
    CANCER LETTERS, 2025, 617
  • [26] Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
    Hoelzel, Michael
    Bovier, Anton
    Tueting, Thomas
    NATURE REVIEWS CANCER, 2013, 13 (05) : 365 - U95
  • [27] Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
    Michael Hölzel
    Anton Bovier
    Thomas Tüting
    Nature Reviews Cancer, 2013, 13 : 365 - 376
  • [28] Identity fraud: Lineage plasticity as a mechanism of antiandrogen resistance and target for therapy.
    Davies, Alastair
    Bostock, Chiara
    Ahmed, Musaddeque
    Lin, Yen-Yi
    Johnson, Fraser
    Nip, Ka Mun
    Ketola, Kirsi
    Bishop, Jennifer
    Fazli, Ladan
    Goodrich, David
    Hach, Faraz
    He, Hansen
    Beltran, Himisha
    Zoubeidi, Amina
    CANCER RESEARCH, 2018, 78 (16) : 41 - 42
  • [29] Tumor Heterogeneity, Clonal Evolution, and Therapy Resistance: An Opportunity for Multitargeting Therapy
    Calderwood, Stuart K.
    DISCOVERY MEDICINE, 2013, 15 (82) : 188 - 194
  • [30] Phenotype plasticity-a novel mechanism of targeted therapy resistance.
    Cyrta, Joanna
    Wilkes, David
    Chae, Sung Suk
    Benelli, Matteo
    Bareja, Rohan
    Prandi, Davide
    Cavaliere, Paola Maria Giovanna
    Beltran, Himisha
    Sboner, Andrea
    Demichelis, Francesca
    Rubin, Mark A.
    CANCER RESEARCH, 2018, 78 (16) : 22 - 22
12345